Announcements
Cardihab joined Ultra106five to help them highlight the benefits of cardiac rehabilitation for people living in Tasmania
Cardihab CEO Helen Souris joined radio presenter David Wood from Ultra106five to discuss the challenges associated with attending traditional cardiac rehabilitation and how Cardihab's digital platform is supporting clinicians to deliver the important continuity of care to patients, particularly through COVID disruptions.
For patients, travel and time constraints were noted as key barriers to participation in traditional cardiac rehabilitation, and currently participation rates are low with only 20% of eligible patients accessing programs. This means that 8 in 10 people are missing out on life changing and necessary care that could prevent a subsequent cardiac event, and even save lives.
With this in mind, Helen discussed results of a study recently published in JMIR that demonstrated a substantial increase in participation from 21% to 63% when our Cardihab platform was offered to patients that declined traditional cardiac rehab programs.
Tasmanians state-wide have a unique opportunity in that all hospitals within the Tasmanian Health Service have Cardihab as part of an initiative to increase access and participation in cardiac rehabilitation. Offering patients a choice of a digital program is a significant step towards improving participation rates and the associated benefits and outcomes.
You can listen to the full segment via this link: https://ultra106five.com/important-findings-cardiac-patients/
Read the full JMIR Cardio publication: The Impact of a Mobile App on Participation in Cardiac Rehabilitation and Understanding Barriers to Success: Comparative Cohort Study
Contact Cardihab for more details.
Cardihab’s “game changing” increase in patient participation is discussed on Dr Ross Walker’s 2GB radio show
It was great for Cardihab to appear on Dr Ross Walker's Healthy Living 2GB radio show. As a cardiologist, Dr Walker has always said cardiac rehabilitation is a vital part of a patient’s recovery from cardiac events and recognises that participation rates are a key challenge to improving outcomes.
The focus of the segment was for Cardihab CEO Helen Souris to discuss the results of the recently published study in JMIR that demonstrated substantial increases in participation from 21% to 63% when our Cardihab platform was offered to participants that declined traditional cardiac rehab programs.
As Dr Walker described cardiac rehabilitation is a comprehensive supervised program of regular physical exercise, education, and medicine management supported by clinicians and Cardihab can enable patients to receive this comprehensive program in the convenience of their home.
You can listen to the full show podcast via this link: Healthy Living Full Show Podcast (Cardihab segment starts at 13:35min)
Read the full JMIR Cardio publication: The Impact of a Mobile App on Participation in Cardiac Rehabilitation and Understanding Barriers to Success: Comparative Cohort Study
Contact Cardihab for more details.
Clinical study finds that offering digital health platform Cardihab increases participation in cardiac rehabilitation
A clinical study of patients with cardiovascular disease by Queensland Cardiovascular Group has found that offering a digital health platform, Cardihab, substantially improved participation rates in cardiac rehabilitation.
The findings were published in the cardiovascular medicine journal JMIR Cardio and revealed that participation in cardiac rehabilitation improved from 21% to 63% when app-based cardiac rehabilitation (SmartCR) was offered as an alternative in addition to a conventional in-person program.
Cardihab provides a digital platform and patient apps (SmartCR) that facilitate the virtual delivery of cardiac rehabilitation and chronic disease management programs for patients recovering from cardiac events and living with heart disease.
The study involved 204 patients who were offered cardiac rehabilitation post angioplasty.
Cohort 1 comprised 99 patients who were offered conventional cardiac rehabilitation only. Cohort 2 comprised 105 patients who were offered Cardihab as an alternative if they declined conventional cardiac rehabilitation.
Patients in each cohort were monitored throughout a 6-week cardiac rehabilitation program, and participation rates were compared for both groups.
Dr John T Rivers, director of the Queensland Cardiovascular Group and lead author, said that cardiac rehabilitation was recommended and improved outcomes for patients, but poor patient uptake remained a challenge.
“The emphasis on continued close involvement by the clinical team was a key success factor. The inclusion of digital health should be considered as another tool in program delivery. Cardiac rehabilitation reduces cardiovascular mortality and increase quality of life, but many people don’t participate because of geographic distance or lack of transport, time constraints as well as cultural, cost and psychological barriers. The improved uptake of cardiac rehabilitation following the addition of SmartCR suggests that a significant number of patients will benefit from the convenience and flexibility of a remotely delivered virtual program. The low readmission rates were also an encouraging outcome that warrants further exploration.” [Dr Rivers]
Helen Souris, Cardihab’s Chief Executive Officer, said that Cardihab enables patients to participate in a care plan that fits within their life.
The structured yet personalized program means that patients are getting high-quality care, while completing a specific program tailored to their individual needs.
“Cardihab provides an important option to help overcome barriers to participation in conventional in-person cardiac rehabilitation programs. Patients do not have to travel long distances to attend a program – they complete it from home while under clinical supervision. Cardihab also helps fit in with peoples’ busy work schedules and family commitments, and alleviates cost and time constraints associated with traditional programs. It has been a critical alternative particularly during COVID-19 whereby significant disruptions to traditional programs have been experienced Australia wide, and social distancing requirements presented further barriers to participation.”[Ms Souris]
Other key insights
- App-based cardiac rehabilitation offered to those declining conventional cardiac rehabilitation can improve participation rates;
-
- The study found that providing the additional option of Cardihab was associated with an increase of 42% in overall cardiac rehabilitation participation;
- Participation in conventional in-person cardiac rehabilitation in Cohort 1 was 21% while that with the added option of Cardihab in Cohort 2 was 63%;
- Approximately 23% of patients in Cohort 2 who declined any cardiac rehabilitation program identified technology issues as the reason why they declined use of the digital platform. Approximately 26% did not participate in either conventional or digital cardiac rehabilitation because they were scheduled for further cardiac procedures. Others declined because of psychosocial issues, frailty or comorbidities, and other reasons;
- This study was not powered to address differences in readmission rates, but the very low rate of 4% observed for app-based cardiac rehabilitation compared to that in other groups is hypothesis-generating.
- Readmission after major cardiac events is a significant and costly problem [1], with 30-day rates estimated between 6%-27% and 12-month rates estimated at 20%-30%.
References:
[1] Chew DP, Scott IA, Cullen L, et al. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes. Heart Lung Circ 2016Sep;25(9):895-951. PMID: 27476580, DOI: 10.1016/j.hlc.2016.06.789.
[2] Janssen V, De Gucht V, Dusseldorp E. Lifestyle modification programmes for patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials Eur J Prev Cardiol 2013 Aug;20(4):620-640. PMID: 23022703, DOI: 10.1177/2047487312462824.
Digitising Cardiac Care: A year of change – more for the better
Our inspiration and motivation comes from the people whose lives we help change.
We all hoped we would be rejoicing a farewell to the pandemic and its associated hardships, in our end of year reflections. It has been a challenging year. But knowing our solution is enabling vulnerable people to stay connected to quality health care, despite the disruptions, is a good feeling. Our inspiration and motivation comes from the people whose lives we are changing.
“God, grant me the serenity to accept the things I cannot change, the courage to change the things I can, and the wisdom to know the difference.”
The context in which Reinhold Niebuhr delivered his famous, soulful Serenity Prayer more than 70 years ago, is different to the one I write now. But it speaks to me very clearly as the CEO of an innovative technology start-up in the healthcare industry, as if it were written only yesterday.
"Improving access to quality care is something we can change."
Access to care, from the perspective of innovation, has two distinct parts:
Treatment and prevention through digital health
Firstly, treatment to improve and/or save the lives of existing cardiac patients. And secondly, proactively improving the quality of life of people, to prevent the likelihood of them becoming patients in the future.
Enabling change through digital health
The motivation for digital health innovation is not about technology itself. It is about people.
In striving to deliver meaningful improvements for patients, there are important considerations surrounding the practices which underpin the delivery methodology and the burdens faced by healthcare practitioners who deliver care.
Technology has made incredible differences to how people live and procure goods and services. It is now dramatically improving the way healthcare is delivered and received.
Patients today are better informed and engaged with their own health and the technology options available. The digitisation of healthcare has also led to higher expectations.
Telehealth consultations are now commonplace and recent announcements regarding permanent Medicare Benefits Schedule funding have secured its future in Australia.
However, there is much more that needs to be done to support the adoption of validated digital health solutions and to ensure products such as Cardihab reach their full potential in delivering improvements in chronic disease management and post event cardiac care.
Digital health implementation requires courage and persistence
We know that technology in healthcare is a positive thing. Healthcare professionals and system administrators know it as well.
We also know that healthcare professionals take continuous improvement seriously. They approach change cautiously and invest time in professional development.
"It takes time to upskill, to change habits, to learn new technology, new delivery methodology."
And one thing no healthcare professional can claim to have in surfeit, especially during the pandemic, is time.
Helping healthcare professionals embrace digital health change
A key priority for any digital health company, is identifying ways to better support change so that innovation can be more efficiently and more seamlessly integrated into the delivery of care.
While there is no one all-encompassing answer to this conundrum, two of our key drivers for change are demonstrating the impact on patients in treatment and prevention and the improvements in clinical workflows for healthcare professionals. Most importantly we recognise the importance of collaboration and partnerships to achieve real change.
Celebrating the change we are making
The burdens of the pandemic have been lightened thanks to the positive experiences of our customers and their patients, who have championed change in the way they deliver and receive care.
Their stories about how they felt supported and motivated through the use of our technology while the world around them was thrown into chaos, was inspirational. It gave us courage to explore even greater goals.
Our wisdom this year has grown, as has our resolve to support and collaborate with the pioneers of change in the health system who are embracing digital health.
We will observe the things we cannot change with patience, celebrate the things we can, and implement positive change with relish.
On behalf of our team at Cardihab, we wish everyone a restful and rejuvenating festive season, and a bright and fresh new year filled with opportunity, happiness and wisdom.
All the best, Helen
CEO, Cardihab
Cardihab selected as part of the $20M ANDHealth+ Digital Health Accelerator cohort
Australia’s only not-for-profit digital health commercialisation organisation, ANDHealth today announced that Cardihab has been selected to take part in its Medical Research Future Fund (MRFF) funded ANDHealth+ program.
The five companies selected in the first ANDHealth+ cohort will share in a pool of $3.75M of project funding via the ANDHealth Digital Health Accelerator Fund and over $500k of pre-screened expert professional services.
Based on the past performance of companies that participated in the smaller ANDHealth+ Pilot Program, ANDHealth+ cohorts in the next four years can expect to create 1000 jobs, impact over 500,000 patients, undertake 175 clinical trials, raise over $130M in new financing and generate $80M in new revenues over the next eight years.
Over 120 companies expressed interest in the program, with 58 completing the comprehensive application process. The five companies selected were assessed through a rigorous process by a multi-sectoral, multi-disciplinary panel of industry leaders and approved by ANDHealth’s recently announced International Investment Advisory Committee.
Digital health startup Cardihab is changing clinical care for people with cardiac disease
Australian digital health startup Cardihab is changing the lives of thousands of people with cardiac disease – the world’s biggest killer. Cardihab’s patient-centred virtual care platform provides a new solution to chronic disease management and is engaging more patients in life changing cardiac rehabilitation. Cardihab CEO Helen Souris tells us how clinicians are stepping up to patient demands for digital health.
Digital health is changing the future of cardiac care
Digital health is bringing new solutions that are transforming the lives of thousands of people with cardiac disease.
More clinicians are exploring advances in digital models of care given COVID-19 has increased patient expectations for it to be a part of their healthcare solutions.
Read more on Wild Health: https://wildhealth.net.au/digital-health-is-changing-the-future-of-cardiac-care/
Cardihab joins the discussion with AstraZeneca and Slush on the next generation of healthcare
In October 2021, AstraZeneca and Slush joined forces with a few start-ups and entrepreneurs for a collaborative event providing a platform for forward-thinking discussions with the potential to shape the next generation of healthcare.
Cardihab participated in this event where innovators, entrepreneurs, and the founders of new healthcare solutions start-ups came together and shared their knowledge and visions.
Cardihab CEO Helen Souris has taken part and elaborated upon the impact of female leadership.
See more on LinkedIn where you can view a short video about the event.
Digital care post-covid: not a tsunami, just a big wave
Countless new health tech innovations may have popped up over the past two years, but has it been enough to overcome hesitancy toward telehealth – not just in the general public, but within the medical profession too?
Cardihab being used in a world leading long COVID study
Today the Baker Heart and Diabetes Institute announced a world leading investigation into the long-term heart damage caused by COVID-19. Hundreds of Melbourne COVID-19 survivors are being recruited for the study looking into the effects of what is dubbed "long COVID" — where those who have previously tested positive report complications months after they have recovered.
We are incredibly proud that the Cardihab platform will be utilised in this study to support patients in their disease management and recovery.
Read the announcement on 9News:
For more information on the study please visit the Baker Institute website: https://lnkd.in/gfSchpV
